Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermakor
Anyang-si, Gyeonggi-do, South Koreadermakor.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Dermakor is a South Korean biotechnology company specializing in the development and manufacture of aesthetic and therapeutic medical products. The company focuses on advanced biomaterials, particularly hyaluronic acid-based dermal fillers and mesotherapy solutions designed for anti-aging and skin rejuvenation. Their product portfolio includes the Florice and Teru brands, which utilize proprietary cross-linking technologies to enhance safety and longevity. Beyond aesthetics, Dermakor explores therapeutic applications for its biomaterial platforms in areas such as orthopedics and tissue regeneration.
- Therapeutic areas
- DermatologyRheumatologyMetabolic Disorders
- Modalities
- DeviceSmall moleculePeptidesBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on Dermakor.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermakor.